Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-23-079261
Filing Date
2023-07-10
Accepted
2023-07-10 06:04:05
Documents
38

Document Format Files

Seq Description Document Type Size
1 S-1/A tm237052-13_s1a.htm S-1/A 3612376
2 EXHIBIT 3.1 tm237052d14_ex3-1.htm EX-3.1 194038
3 EXHIBIT 5.1 tm237052d14_ex5-1.htm EX-5.1 5747
4 EXHIBIT 10.5 tm237052d14_ex10-5.htm EX-10.5 116645
5 EXHIBIT 10.9 tm237052d14_ex10-9.htm EX-10.9 45845
6 EXHIBIT 10.24 tm237052d14_ex10-24.htm EX-10.24 20029
7 EXHIBIT 10.29 tm237052d14_ex10-29.htm EX-10.29 15258
8 EXHIBIT 23.1 tm237052d14_ex23-1.htm EX-23.1 2145
9 EX-FILING FEES tm237052d14_ex-filingfees.htm EX-FILING FEES 36700
10 GRAPHIC bc_biomarkerimaging-4c.jpg GRAPHIC 75573
11 GRAPHIC bc_collagen-4c.jpg GRAPHIC 126647
12 GRAPHIC bc_denifanstat-4c.jpg GRAPHIC 31490
13 GRAPHIC bc_fibrosisbio-4c.jpg GRAPHIC 53177
14 GRAPHIC bc_fibrosiss-4c.jpg GRAPHIC 55214
15 GRAPHIC bc_inflammation-4c.jpg GRAPHIC 85489
16 GRAPHIC bc_lipidbio-4c.jpg GRAPHIC 56927
17 GRAPHIC bc_lipotoxicity-4c.jpg GRAPHIC 115107
18 GRAPHIC bc_liverfatbio-4c.jpg GRAPHIC 96998
19 GRAPHIC bc_pipeline01-4c.jpg GRAPHIC 150781
20 GRAPHIC bc_solidtumors-4c.jpg GRAPHIC 88587
21 GRAPHIC bc_tripalmitin-4c.jpg GRAPHIC 26859
22 GRAPHIC bc_weekdosing-4c.jpg GRAPHIC 88246
23 GRAPHIC fc_clinicaltrial-4c.jpg GRAPHIC 73450
24 GRAPHIC fc_clinicaltrial4c.jpg GRAPHIC 66855
25 GRAPHIC fc_denifanstat-4c.jpg GRAPHIC 83698
26 GRAPHIC fc_diseaserationale-4c.jpg GRAPHIC 142821
27 GRAPHIC fc_excessliver-4c.jpg GRAPHIC 83370
28 GRAPHIC fc_metabolic-4c.jpg GRAPHIC 58576
29 GRAPHIC fc_overview-4c.jpg GRAPHIC 97317
30 GRAPHIC fc_pathogenesis-4c.jpg GRAPHIC 177297
31 GRAPHIC fc_patients-4c.jpg GRAPHIC 148180
32 GRAPHIC fc_precision-4c.jpg GRAPHIC 116752
33 GRAPHIC lc_predictive-4c.jpg GRAPHIC 53447
34 GRAPHIC lg_sagimet-4c.jpg GRAPHIC 40042
35 GRAPHIC ph_denifanstat-4c.jpg GRAPHIC 174205
36 GRAPHIC tb_fibrogenic-4c.jpg GRAPHIC 67467
37 GRAPHIC tb_oncology-4c.jpg GRAPHIC 127756
38 GRAPHIC tb_treatment-4c.jpg GRAPHIC 142382
  Complete submission text file 0001104659-23-079261.txt   7674607
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)

IRS No.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-272901 | Film No.: 231078137
SIC: 2834 Pharmaceutical Preparations